PharmaCyte Biotech Updates Progress of cGMP Facility for the Production of Cell-in-a-Box for Clinical Trials
August 06, 2015 09:30 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Aug. 06, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
Chardan Releases Industry Report Covering PharmaCyte Biotech
August 04, 2015 09:00 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Aug. 04, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Begins Second Follow-Up Study on Ascites
July 23, 2015 09:20 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., July 23, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Appoints Renowned Oncologist Dr. Manuel Hidalgo to Scientific Advisory Board
July 16, 2015 09:10 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., July 16, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Appoints American Stock Transfer as New Stock Transfer Agent
July 09, 2015 09:20 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., July 09, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Releases HealthWatch Segment Featured on Discovery Channel
June 30, 2015 08:30 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., June 30, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech’s Cancer and Diabetes Treatments Airing Nationwide on Discovery Channel
June 29, 2015 08:30 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., June 29, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Enters Into Research and Consulting Agreements With University of Technology Sydney
June 23, 2015 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., June 23, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Showcasing Technology and Treatments at 2015 BIO International Convention
June 16, 2015 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., June 16, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Advances Cannabinoid Research With Schedule 1 License
June 15, 2015 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., June 15, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...